|
FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at http://www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch list serve. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to educators in healthcare facilities and academic institutions.
Stories in the November 2008 edition include:
Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade
Strengthened warnings needed to draw attention to fungal infections in patients treated with TNF-alpha blockers…
Serious Injection Site Reactions with Vivitrol
Practitioners should take care to avoid injecting the drug intravenously, subcutaneously, or into fatty tissue…
Healthcare professionals should consider antidiabetic therapies other than Byetta (exenatide) in patients with a history of pancreatitis…
Importance of Influenza Vaccination for Healthcare Personnel
Ensuring that healthcare staff are vaccinated can reduce staff influenza rates as well as nosocomial infection rates…
Increased Risk of Death in Elderly Patients Taking Conventional Antipsychotics for Dementia
Boxed warning to highlight the risk of death when treating dementia-related psychosis with conventional antipsychotics such as Haldol…
Serious Hypersensitivity Reactions with Abacavir (Ziagen)
Patients with the HLA-B*5701 allele may be at increased risk for hypersensitivity reactions…
Serious Muscle Injury with Simvastatin/Amiodarone Combination
Possible increased risk of rhabdomyolysis in patients using cholesterol lowering statins (e.g., Zocor) together with the anti-arrhythmic drug, amiodarone…
Tragic Events with Concentrated Opiate Oral Solutions
ISMP offers recommendations on preventing dosing errors with opiate oral solutions…
FDA’s Drug Safety Newsletter Now Available
The latest Drug Safety Newsletter includes articles on preventing medication errors and exploring associations between reported adverse events and several drugs such as mefloquine hydrochloride, lenalidomide, and icodextrin…
For more
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
